In colorectal cancer, a distinct subset of CD70‐positive CAFs has been identified, which promotes tumour progression by enhancing tumour cell migration and facilitating immune evasion through the accumulation of Tregs.162, 163. This evidence concerns the gene CD70 and neoplasm.